Podcast appearances and mentions of kelly close

Many of the events in a woman's life, like pregnancy and menopause, can cause weight gain. Endocrinologist Dr. Fran Kaufman and patient advocate Kelly Close join us to talk about what women should know about managing weight throughout their lives and also how diabetes medications can affect our weight.

Hamish Carton and Tony Haggery with Wednesday morning's briefing from The Celtc Way To subscribe: https://www.celticway.co.uk/subscribe/ On the website today: Celtic and Rangers' THREE key title race factors this season https://www.celticway.co.uk/opinion/24181005.celtic-rangers-three-key-title-race-factors-season/

Imogen reflects on bodies, history, gender and connection, remembering her mother, an ex-partner and her childhood.Imogen Kelly is a performance artist, writer, director and producer. Hailing from the queer underground, Imogen is renowned as Australia's Queen of Burlesque and was officially crowned World Queen of Burlesque in 2012 (Burlesque Hall of Fame, Las Vegas).
 A La Clique/ La Soiree veteran and creator of award winning burlesque theatre shows, Imogen has performed in The Sydney Opera House, Sydney Festival, Adelaide Cabaret Festival, Vivid Festival, The New York Burlesque Festival, The Noumea Burlesque Festival, Helsinki Burlesque Festival, Prague, New Orleans, Dallas, Austin, Toronto, Hamburg, Berlin and beyond. During COVID Imogen has been making short films of her performance pieces and is preparing for an exhibition in late 2021. This year she is launching three shows in Sydney including The La La Parlour, a quarterly variety night, Herstory- The Walls Are Talking- a trip through the history of Australia's Red Light district as told by the women who worked there, and a gargantuan celebration of her life's work in a retrospective later in the year.Queerstories an award-winning LGBTQI+ storytelling project directed by Maeve Marsden, with regular events around Australia. For more information, visit www.queerstories.com.au and follow Queerstories on Facebook.The Queerstories book is published by Hachette Australia, and can be purchased from your favourite independent bookseller or on Booktopia.To support Queerstories, become a patron at www.patreon.com/ladysingsitbetterAnd for gay stuff and insomnia rants follow Maeve Marsden on Twitter and Instagram. See acast.com/privacy for privacy and opt-out information.

It's "In the News..." the only LIVE diabetes newscast! Top stories this week: -Apple drops a BG hint in the latest watch update -New info about Dexcom's G7 -Omnipod 5 study released -Diabetes drug shows promise for weight loss -Power of peer support Join Stacey live each Wednesday at 4:30pm EDT at https://www.facebook.com/diabetesconnections Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go! Click here for iPhone      Click here for Android Episode Transcription below:    Hello and welcome to Diabetes Connections In the News! I'm so glad you're here! I'm Stacey Simms and each week I'll share the top diabetes stories and headlines of the past seven days.  Whether you're joining me live on Facebook or watching or listening after, I'm here to get you up to speed quickly on what's happening with diabetes technology, research, and our community. Since these are headlines and summaries, as always, you'll find all the sources and links in the Facebook comments and in the show notes at d-c dot com. XX In the News is brought to you by Inside the Breakthrough. A new history of science podcast full of “Did You Know Stuff” XX here's what's In The News this week… Couple of buzzy slides from Apple's World Wide Developer's Conference. First, this one from their WatchOS 8 update.. they didn't use the words blood glucose.. but this slide was shown featuring the graphic “blood glucose highlights.” That likely means pulling the data from existing apps like Dexcom or Dario or One Drop, but there are always rumors about Apple releasing a glucose sensor of their own.  We shall see – thanks to Nerdabetic for bringing this to our attention. Another diabetes shout out in this slide - same presentation - about time sensitive notifications. If you look closely you can see the Happy Bob app, which puts funny messages along with glucose notifications. XX Lots of news out of the recent Advanced Technology and Treatments in Diabetes Conference or ATTD. Dexcom showed this slide about their upcoming G7.  We've reported on this a lot over the last two years, I'll link up our previous episodes. but the new info includes: a 30 minute warm up time as opposed to 2 hours right now, and direct to watch capability. Direct to watch from Dexcom – that means you don't need your phone to see your BG on the watch face anymore - was first announced in June of 2017 with the G5 and that proved more difficult to implement than expected. I'm talking to Dexcom for the podcast later this month so we'll get a update on what this really means. The G7 is a smaller, all in one with sensor and transmitter applied together. It's NOT FDA approved yet so there's no timeline for release. Also, Dexcom put out a study that says people with type 2 who use basal insulin benefit from the use of CGM. The Mobile study took place over eight months. Those who used the CGM increase time in range and showed a full point drop in A1Cs on average. https://twitter.com/ATTDconf/status/1401200753717432328 New data presented on Omnipod 5.. this is just an abstract – full study will be released later this month. This is Insulet's hybrid closed loop system where it works with the Dexcom to keep a user within a targeted blood sugar range. They looked at children and adults ages 6-70 to measure safety of this new system. A1Cs came down, time in range went up, very low occurrence of hypoglycemia and researchers concluded it was safe. The Omnipod 5 operates in two modes, an automated mode and a manual mode. The system provides automatic insulin delivery with customizable glucose targets from 110 to 150, which can be adjusted by time of day. Omnipod 5 with Horizon is in front of the FDA right now so there's no timeline on release.   https://care.diabetesjournals.org/content/early/2021/05/21/dc21-0172   Also at ATTD - DarioHealth looking at outcomes from their highly personalized apps and system. Dario's study found that personalizing the clinical interventions in response to unique individual actions really helps. That's opposed to systems with more generalized predictions. This study showed more frequency in blood sugar testing and monitoring in those who received an personalized intervention. https://www.prnewswire.com/il/news-releases/dariohealth-releases-study-demonstrating-the-impact-of-personalized-digital-interventions-to-improve-self-management-of-diabetes-301305650.html XX Early on here but a new closed loop system that knows when you're eating is being tested – this was a small trial in adolescents and young adults. This is out of UVA – the same place that developed what became Tandem's Control IQ. The researchers say teenagers are particularly prone to skipping meal boluses. This system, known right now as Rocket AP contains an Artificial intelligence bolus priming system that uses CGM to basically decide if you've eaten without bolusing. If it thinks you have, it will automatically dose. The median time in range after a bolused meal was 100% with the Rocket AP system and 93% with the control system, but was a corresponding 83% versus 53% after a meal without a bolus. Again, that's 83% time in range when you completely forget your meal bolus. Bears watching. https://www.medwirenews.com/diabetes/ai-fully-closed-loop-insulin-delivery-type-1-diabetes/19231866 XX Up next.. a diabetes drug is approved for weight loss but first.. quick break – want to tell you about one of our great sponsors who helps make Diabetes Connections possible. Inside the Breakthrough is a podcast that mixes historical wisdom with modern insight – it's a science show that's also entertaining. I love it. The latest episode talks about scientists who knew they were onto something but needed to see things with their own eyes. How actually seeing something like a Kraken? Makes a huge difference. It also meant a name change for what some thought had only been a myth. And this actually relates to diabetes! Listen to Inside the Breakthrough wherever you listen to podcasts.. Back to the news…   The FDA has approved the medication Wegovy (wee-GOH-vee), a higher dose of the diabetes drug semaglutide (semuh-GLU-tide), to be used as a weight management drug in patients with obesity. It's the first drug for chronic weight management that has been approved by the FDA since 2014. It is injected under the skin once a week. People in the study lost an average of 12 percent of their body weight. People with type 2 diabetes lost 6 percent of their body weight. No reason given for the difference and there are some – intestinal side effects – but Wegovy is said to be safer than older weight loss drugs. https://www.healthline.com/health-news/fda-approves-popular-diabetes-medication-for-use-as-weight-loss-drug   XX The power of peer support was shown at ATTD in a presentation by Kelly Close and Diatribe. Their survey showed engagement in the diabetes online community didn't just make people feel better emotionally, which is great, but it also predicted better glycemic outcomes.. those most involved in the community increased their chance of having an A1C under 7. That's Diabetes Connections – In the News.  If you like it, share it. And feel free to send me your news tips. Stacey @ diabetes dash connections dot com. Please join me wherever you get podcasts for our next episode -Tuesday – we're talking to the folks from Beta Bionics for the first time in a long time to get an update on the iLet pump. And the episode that's out right now is all about what college students want you to know. Thanks and I'll see you soon

Blue Belle disputes footage from protests. 100 Percent Invisible investigates the history of the super-suit. On the Speech Bubble, Kelly Close interviews the Guinness World Record holder for being kidnapped. Full Episode Credits Available Here SPR is listener supported. Please consider joining our Patreon to get ad-free episodes and early access to next week's stories* https://www.patreon.com/sprpod This episode of SPR is distributed to Earth 955x by John Dorsey and Maximilian Clark from JPWR Paradise City. *Early access is provided by Franklin, within the confines allowed by international law. -------------------------------------------- Music: Beauty Flow by Kevin MacLeod Link: https://incompetech.filmmusic.io/ License: http://creativecommons.org/licenses/by/4.0/ An Eve of Galas by Radio Night epidemicsound.com City Fashion by Nathan Welsh epidemicsound.com

Live coverage of Cosmos v. US Attorney General. Full credits available here SPR is listener supported. Please consider joining our Patreon to get ad-free episodes and early access to next week's stories* https://www.patreon.com/sprpod -------------------------------------------- This episode features music composed for SPR by Roc Lee and Stephen Munoz as well as tracks licensed from Epidemic Sound: Chicken Got No Head by River Foxcroft Old Folk's Dance by Stationary Sign What I'm Asking by Eric Feinberg Your Woman by Lindsey Abraham The Speech Bubble is produced by Kelly Close and JDHC Houston. This episode of These American Supers is produced by Ethan Schwartz, Ellen Spiegel and QSPZ Baltimore. This episode of SPR is distributed by John Dorsey and Maximilian Clark from JPWR Paradise City. *Early access is provided by Franklin. Do not let him near your phone.

Robin chats with Kelly Close, founder and chair of the board of the diaTribe Foundation, a nonprofit dedicated to improving the lives of people living with diabetes and prediabetes, and advocating for action and Adam Brown, who serves as senior editor at diaTribe.org and head of diabetes technology & connected care at Close Concerns. There are more than 400 million people globally who have diabetes, about half of whom are undiagnosed, notes Brown. Historically, he says, technology has focused on Type 1 diabetes, but now and, in the future, there will be more of a focus on Type 2 diabetes, with the current capability of using continuous glucose monitoring (CGM) and the burgeoning use of smart phones and apps. Companies are going to have to demonstrate that this transformative technology produces better outcomes, he explains, so expect more studies of what happens when patients get real time glucose readings every five minutes. Technology can be used for more personalized prevention, treatment, and care, adds Close. There are scientific innovations, she says, which provide breakthrough therapies for cardiac issues related to diabetes, resulting in increased attention to access issues.  Having access to vital diabetes information, such as how much insulin is needed, empowers patients to engage in increased self-care, she adds. Pharmaceutical companies are “leaving diabetes,” Close notes, which just magnifies the importance of technology. However, Brown says, pharmaceutical companies, such as Eli Lilly, are investing in technology, including the use of pens, while CGM companies are focusing on software development. In terms of innovators, it’s important that they keep in mind the necessity of patient access and awareness, both Close and Brown assert.  

Kelly Close founded Close Concerns in 2002; its mission is to make everyone smarter about diabetes. At Close Concerns, Kelly and her team write approximately three million words each year on diabetes, prediabetes, obesity, and digital health for Closer Look, a highly praised service covering the goings-on in the field. Kelly's passion for the field comes from her extensive professional work as well as from her personal experience, having had diabetes for over 30 years. Kelly is the author of more than 30 peer-reviewed manuscripts as well as Targeting a Cure for Type 1 Diabetes: How Long Do We Have to Wait?, a widely praised book published by the American Diabetes Association (ADA) in 2013. She also wrote the foreword for the widely praised Bright Spots & Landmines by Adam Brown, published in 2017. Kelly is an associate editor of Clinical Diabetes, a journal focused on diabetes for primary care physicians published quarterly by the ADA. Close Concerns is a winner of the ADA’s “Excellence in Health Communications” Award, and Kelly and her team write a quarterly column in Journal of Diabetes, a peer-reviewed journal based in Shanghai. Kelly chairs the diaTribe Foundation, a nonprofit established in 2013 to improve the lives of people with diabetes and prediabetes and to advocate for action. She is also the founder of diaTribe.org, begun in 2006 as an educational resource for people with diabetes; diaTribe.org’s free educational mailers go to over 100,000 people every 2 weeks. Before starting Close Concerns and the diaTribe Foundation, Kelly’s work focused on life sciences more broadly. Over nearly a dozen years, she worked on Wall Street (investment banking at Goldman Sachs, equity research at Merrill Lynch) and at McKinsey & Company, where her work centered on life science, managed care, and nonprofit organizations. Kelly has a BA in economics and English from Amherst College, magna cum laude, and an MBA from Harvard Business School. She was a founding board member of the Institute for Responsible Nutrition, led by University of California, San Francisco’s Robert Lustig, MD, and a previous executive board member of the Diabetes Hands Foundation and the Behavioral Diabetes Institute. She and her husband and three children are cohosts of the popular San Francisco–based discussion series CPS Lectures. 01:22 Why Kelly started diaTribe. 02:22 Empowering patient decisions and disease management. 03:51 The power of numbers in making change. 04:12 Other advocacy groups inside and outside the diabetes realm. 05:09 Paying attention to direct costs as well as indirect costs. 05:44 The four areas of constraints to obtaining the outcomes desired in treating diabetes. 06:34 Behavior design and behavior change. 07:52 Overcoming diabetes constraints. 08:18 “You can’t know where you want to go with your diabetes management until you know where you are.” 10:10 Supporting patients and continuous glucose monitoring. 13:01 “What’s not going well here, and what’s changeable?” 15:18 “Until we’re doing much more to create healthy communities and supporting communities, we will not be successful.” 15:52 Go to diatribe.org/brightspots for educational materials for your diabetes patients. 17:00 Avoiding stigmatizing language. 17:40 Ensuring you have a diabetes educator or social worker who understands what resources are available. 17:51 Finding community organizations like Wellville—EP118 with Rick Brush. 18:40 The dichotomy of engaged patients vs those who aren’t. 19:39 The importance in understanding where patients are coming from and their emotional well-being. 21:24 The impressiveness of Kaiser moving half of their appointments to telehealth. 23:02 Health technologies helping to improve diabetes outcomes and how they are finding reimbursement. 24:46 Innovated payers funding diabetes research to improve outcomes. 25:48 The excessive expenses associated with diabetes today. 28:12 “The only good thing about this spending ... [is] that a lot could happen to reduce that.” 28:59 Houston’s efforts to make an impact on diabetes in the community level. 30:44 “I think today the really forward-thinking companies are really thinking about stakeholder value.” 32:10 You can learn more by going to diatribe.org, follow diaTribe on Facebook and Twitter, and check out diatribe.org/foundation and diatribe.org/brightspots.

Special Mother’s Day message for the whole church. In this message Kelly Close shares from her experiences of motherhood and how it relates to walking in the Fruit of the Spirit. Listen as Kelly focuses on the importance of allowing the Fruit of the Spirit to be mixed in to every area of our lives. The post Fruit of the Spirit – Pt.3 – Mother’s Day appeared first on New Beginnings Christian Fellowship.

2011 Roche Social Media Summit at the Hard Rock Hotel in San Diego, California. At the afterparty, Charlie Cherry interviews Manny Hernandes, George Simmons, Ronnie Gregory, Kelly Kunik, Bernard Farrell, Kerri Morrone Sparling, Kelly Close, Scott Strumello, Amy Tenderich, Mike Durbin, Chris Stocker, Wil Dubois, Scott Johnson.  

Guest: Kelly Close, MBA Host: Steven Edelman, MD The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up, Kelly Close, as they discuss the challenges of both regulation and reimbursement.

On this week's show, we welcome Kelly Close and Amy Tenderich. Kelly and Amy, along with Manny Hernandez, founder of TuDiabetes.com and with the support of many other leaders in the Diabetes community, are conducting a petition drive to the FDA.We fear that innovation is slowing in Diabetes, despite the urgent need for new treatments. Today, close to half of the 24 million Americans with Diabetes do not meet recommended blood sugar goals. The U.S. Food and Drug Administration's job is to protect the safety of patients and approve innovative medicines. We are asking the new FDA leadership for two things:1. To create a council of Diabetes patients and health care professionals who can help the FDA assess new information and assimilate diverse opinions, including those of patients.2. To make the rules reasonable for the sake of the patients, which can be done without sacrificing safety. http://www.helpthefda.org/Please note: This petition is sponsored by a group of concerned patients, doctors and Diabetes educators, not the drug industry.